after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

Only need another 0.04 and Its gone up in a day by what I bought them at.
How happy???
Alan

At that mid price (3.45) its officially a 5 bagger for me.
A small sweet sherry to celebrate, methinks.
Alan

What, not pie, peas and bread & dripping with a nice pint?! Congratulations!
Kim

price has gone up more then i thought over the last few days lets hope it stays here without to much retracement

Congratulations Alan!

Thanks, but not my tip. The congrats go to those who tipped it!!
I'll just settle for the money!!!
Plenty more yet, I think.
Alan

To think that two days ago I was worrying about an exit strategy for this one and wondering if the time had come to move on!!
What a difference a couple of days makes.
Thanks to those that persuaded me to keep holding.
Alan

alan not only the people that tipped it also the congrats should go to peps that did not lose the faith in the bad times and kept buying at cheap levels.

good to see your still here woodie.

good day tommorow methinks!

pbo

pbo thanks always look in when there is a post.

Blimey, what a day!!! I have had a look on the chart and see thet ULT have been as high as 70p. If only eh

So it's official....wilbs can see into the future! ;-).

I wish!!!!

See, I told you.

Was it Yaz who sang 'The only way is up'? The film 'Back to the future' springs to mind too (year 2000?)!

Yazz & The Plastic Population

No, isn't that something to do with Stanelco?!

So, BTB has been approved. Now we need contract confirmation.

NICE document here:

http://www.nice.org.uk/page.aspx?o=293240

So beating the blues has been recommended by NICE. Thats confirmed. All that is left is contracts, and they will come.

NICE PRESS RELEASE

NICE issues guidance on computerised cognitive behavioural therapy for treating mental health problems.

The National Institute for Health and Clinical Excellence (NICE) has today
issued guidance to the NHS in England and Wales recommending two
computerised cognitive behavioural therapy (CCBT) packages, widening the available options for treating people with depression and anxiety.

This guidance updates previous NICE technology appraisal guidance No51
from October 2002 and concerns five specific packages for the delivery of
computerised cognitive behaviour therapy, accessed via a referral from a
general practitioner (GP): three for depression (Beating the Blues, COPE andOvercoming Depression), one for panic/phobia (FearFighter) and one for obsessive compulsive disorder (OCD) (OCFighter, previously known as
BTSteps).

After considering the evidence, the Institutes independent Appraisal
Committee came to the following conclusions:

Beating the Blues is recommended as an option for delivering cognitive
behaviour therapy (CBT) in the management of mild and moderate
depression.

There is insufficient evidence to recommend the use of COPE and
Overcoming Depression as a clinically or cost effective option for the
management of depression, except as part of ongoing or new clinical
trials that are designed to generate robust and relevant data on the
clinical effectiveness of these specific CCBT packages.

FearFighter is recommended as an option for delivering CBT in the
management of panic and phobia.

OCFighter (previously known as BTSteps) is not recommended as an
option for delivering CBT in the management of OCD.

People currently using OCFighter, whether as routine therapy or as
part of a clinical trial, may be continued on therapy until the person, or
the GP and/or specialist, consider it appropriate to stop.

Professor Peter Littlejohns, Clinical and Public Health Director at NICE
and Executive Lead for the guidance, said: Todays guidance will make a
real difference in terms of increasing the range of options available to patients suffering from depression and anxiety. It provides clear advice to the NHS and patients, no matter where they live in England and Wales, on where CCBTtreatments can add value.

Ends